Core Viewpoint - Yunnan University has announced procurement intentions for 25 items of laboratory equipment, with a total budget of 169 million yuan, scheduled for procurement between February and May 2025 [1][2]. Procurement Overview - The procurement includes advanced instruments such as molecular interaction analyzers, multifunctional enzyme labelers, plasma focused ion beam cryo-electron microscopes, triple quadrupole liquid chromatography-mass spectrometry systems, and high-speed confocal microscopes [2][4]. - The total budget for these instruments is 169 million yuan, indicating a significant investment in research capabilities [1][2]. Specific Equipment and Budget - Molecular Interaction Analyzer: 1 set, unit price 3.1 million yuan [5]. - Multifunctional Enzyme Labeler: 1 set, unit price 1.46 million yuan [5]. - Plasma Focused Ion Beam Cryo-Electron Microscope: 1 set, unit price 20 million yuan [5]. - Triple Quadrupole Liquid Chromatography-Mass Spectrometry System: 1 set, unit price 3.3 million yuan [5]. - High-Speed Confocal Microscope: 1 set, unit price 3.9 million yuan [5]. Procurement Goals - The procurement aims to enhance research capabilities in various fields, including photovoltaic materials, electrochemical testing, and molecular biology, supporting the development of high-performance technologies [4][5]. - The equipment will facilitate comprehensive research processes from theoretical design to performance evaluation, particularly in the fields of materials science and life sciences [4][5]. Compliance and Standards - All procured equipment must meet national safety and environmental standards, ensuring compliance with mandatory energy-saving and environmental protection regulations [4][5][6].

导读： 2025 年5 月22 日，禾信召开第四届董事会第一次会议，选举产生了董事长及董事会专门委员会委员，并聘任新一届高级管理人员。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 广州禾信仪器股份有限公司（以下简称"公司"）于2025 年5 月22 日召开2025年第一次临时股东会选举产生了第四届董事会董事。2025 年 5 月22 日，公司召开第四届董事会第一次会议，选举产生了董事长及董事会专门委员会委员，并聘任新一届高级管理人员。 董事长选举情况 2025 年 5 月 22 日，公司召开第四届董事会第一次会议，审议通过《关于选举公司第四届董事会董事长的议案》， 全体董事一致同意选举 周振先生担任公司第四届董事会董事长 ，任期自本次董事会审议通过之日起至第四届董事会任期届满之日止。 董事会专门委员会选举情况 2025 年 5 月 22 日，公司召开第四届董事会第一次会议，审议通过《关于选举公司第四届董事会各专门委员会委员及召集人的议案》，选举 产生公司第四届董事会专门委员会委员及召集人，任期自本次董事会审议通过之日起至第四届董事会任期 ...

Core Viewpoint - JD.com is actively recruiting a head for its Cell Research Institute with a salary of one million, indicating its strategic focus on cell therapy as a significant breakthrough in the high-end medical services sector, with "cell storage" as a core business entry point [1][3][5]. Group 1 - The recruitment of a head for the Cell Research Institute has sparked discussions within the cell and gene therapy (CGT) industry [3]. - The job requirements highlight the need for experience in the commercialization of cell therapy products and practical experience with at least one CGT product's IND progress, suggesting JD.com's serious commitment to this field [5]. - JD.com has shown a strategic determination to deeply engage in the cell therapy sector, leveraging its strong financial resources, large user base, and e-commerce platform traffic to potentially disrupt traditional industry competition [8].

Core Viewpoint - Digital PCR technology is recognized as a revolutionary force in the field of molecular diagnostics, offering absolute quantification capabilities, high sensitivity, and specificity, which are essential for applications such as early cancer screening [1][3]. Group 1: Digital PCR Technology - Digital PCR is referred to as the third generation of PCR technology, showcasing significant advancements in automation and high-throughput detection efficiency [1]. - The technology is expected to provide reliable technical support for clinical applications, particularly in tumor early screening [1]. Group 2: Upcoming Conference - The "9th PCR Technology and Application Online Conference" will be held on May 28, 2025, organized by Instrument Information Network [3]. - The conference will feature various experts and scholars discussing the latest developments and innovative applications of digital PCR technology [1][3]. - A detailed agenda includes presentations on ultra-sensitive detection of low-frequency gene mutations, nucleic acid standard materials, and integrated high-sensitivity nucleic acid rapid detection technologies [3].

Core Insights - The article emphasizes the growing importance of clinical mass spectrometry in precision medicine, highlighting its unique advantages such as high specificity, sensitivity, and multi-parameter detection [3]. Market Overview - As of May 26, 2025, two clinical mass spectrometry instruments and twelve reagent kits have been approved. The global clinical mass spectrometry market is projected to reach $930 million by 2024, with an expected growth to $1.435 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9% [3]. Clinical Applications - **Intraoperative Diagnosis of Brain Gliomas**: The article discusses the use of portable mass spectrometry for rapid identification of IDH mutations in brain gliomas, which significantly improves patient prognosis. A study conducted by a team from Fudan University and other institutions achieved a 100% accuracy rate in detecting IDH mutations in 697 samples from 260 glioma patients [4]. - **Therapeutic Drug Monitoring (TDM)**: Mass spectrometry is becoming a crucial tool in TDM, particularly for high-risk drugs like monoclonal antibodies. The nSMOL (nano-surface and molecular orientation limited) technology has enhanced specificity and sensitivity in measuring total drug concentrations, supporting personalized treatment for complex diseases [5]. Challenges and Future Directions - Despite the advancements, the transition of mass spectrometry from the laboratory to clinical settings faces challenges such as complex sample preparation, lack of standardized protocols, insufficient automation, and limitations in speed and cost. The article also mentions the importance of standard materials for ensuring accurate measurement in clinical chemistry [6].

Core Viewpoint - The "2025 Beijing Spectroscopy Annual Conference" aims to promote the healthy development of spectroscopy, encourage academic exchanges, and support the technological advancement of domestic spectroscopy instrument companies [3][7]. Group 1: Conference Overview - The conference was held on May 24, 2025, in Beijing Huairou Science City, organized by the Beijing Society of Physical and Chemical Analysis and the Beijing Spectroscopy Society, with support from the Chinese Academy of Sciences and Tianjin Medical University [3][4]. - The theme of the conference is "Innovation and Integration Driven by Interdisciplinary Spectroscopy," focusing on the latest advancements in various spectroscopy techniques [7]. - The event attracted over a hundred professional representatives from universities, research institutes, and technology companies across the country [4]. Group 2: Conference Activities - The conference included 11 keynote reports, 14 technical reports, 12 youth forum presentations, and 16 poster displays, showcasing the latest achievements in nuclear magnetic resonance (NMR) technology [7][8]. - Awards such as the "2025 Beijing Spectroscopy Conference Outstanding Contribution Award" and various youth awards will be presented during the conference [8]. Group 3: Keynote Reports - Reports covered topics such as high-field NMR applications in chemical research, the development of new trityl radicals for electron paramagnetic resonance, and the application of artificial intelligence in NMR spectrum editing [15][18][21]. - Notable advancements include achieving nearly 1000 times NMR signal enhancement through dynamic nuclear polarization and exploring the role of free radicals in tumor treatment [24][30]. Group 4: Industry Support and Future Directions - The conference received strong support from several companies, including Suzhou Newmai Analysis Instrument Co., Ltd. and Guoyi Quantum Technology (Hefei) Co., Ltd., highlighting the importance of collaboration in advancing domestic scientific instruments [49]. - Guoyi Quantum emphasized the need for quality, service, and cost-effectiveness in domestic instruments, aiming to shift from "replacement" to "leadership" in the industry [40].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近 年 来 ， 全 球 锂 电 产 业 规 模 持 续 扩 张 。 2024 年 我 国 锂 电 总 产 量 达 1170GWh ， 同 比 增 长 24% ， 行 业 总 产 值 突 破 1.2 万 亿 元 大 关 （ 工 信 部 数 据）。随着新能源应用场景的不断拓展，检测技术已成为推动行业高质量发展的关键引擎。 作为行业标杆会议，"锂离子电池检测技术与应用"网络会议已成功举办六届，累计吸引近万名专业人士参与。 2025年5月27-29日，第七届 会议将再次升级 ，汇聚产学研用顶尖专家，聚焦"实验室到产线"的全链条技术创新，内容覆盖 锂电原材料成分分析技术 、 锂电原材料 物理 性能分析技术 、 锂电 热安全分析技术、锂电 失效机理与分析技术、 固态电池与钠电分析技术前沿进展 等，为行业发展提供专业交流平台， 助力相关产业可持续发展。 诚邀业界同仁踊跃报名，共襄盛举！ 会议时间： 2025年5月27-29日 主办单位： 仪器信息网 会议全日程： | Q 09:30 -- 10:00 | 电 ...

Core Viewpoint - In April 2025, Fuxiang Optics successfully secured nearly 100 million yuan in C+ round strategic investment, led by top industry institutions such as Pucheng Fund and Yuanhe Puhua, to advance the construction of its new headquarters and production lines, as well as core technology breakthroughs [1][2]. Group 1 - Fuxiang Optics has a top-tier R&D team in China, having served over 4,000 clients and sold more than 30,000 spectrometers, securing a leading position in the high-end spectrometer market [4]. - The investment will facilitate the construction of a new headquarters exceeding 5,000 square meters, creating an integrated innovation platform covering R&D, testing, production, and marketing, with a potential capacity scale of nearly 1 billion yuan [4]. - The company has pioneered a deep spectral technology architecture that integrates artificial intelligence algorithms, continuously enhancing its independent innovation advantages in the high-end optical instrument sector [4]. Group 2 - Fuxiang Optics aims to deepen collaboration with research institutions and upstream and downstream partners in the industry chain, focusing on key areas such as micro-nano manufacturing, photonic integration, and biomanufacturing to overcome core technological bottlenecks [4]. - The company is committed to expanding its open ecosystem around deep spectral technology, providing exceptional end-to-end integrated intelligent optical sensing technology solutions, and contributing to the high-quality development of national strategic emerging industries [4].

导读： 近日，康复大学发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出8项仪器设备采购意向，预算 总额达1.89亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，康复大学发布8项仪器设备采购意向，预算总额达1 . 8 9亿元，涉及小动物活体成像系统、动物专用全自动血细胞 分析仪、动物专用生化分析仪、动物用尿液分析仪、切片染色扫片、高速冷冻离心机、胚胎移植显微操作系统等，预计 采购时间为2 0 2 5年5~6月。 | | | 预算 | 采 | | --- | --- | --- | --- | | 采购项目 | 需求概况 | 金额 | 购 | | | | / 万 | 时 | | | | 元 | 间 | | 康复工程专 | | | 202 | | 业实验室 | 拟采购康复工程专业实验室（适老化改造实验室）设备，为满足学校发展和教学需求，需采购公共教学平台设备一宗，包 | | 5 | | （适老化改 | 含多功能床、移位机、助浴设施等设备一批。该项目提供设备安装调试等服务，质量、安全等符合国家、省市及行业相关 | ...

导读： 近日，中国石油大学（华东）发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理，统计出55项仪器设备采 购意向，预算总额达1.26亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，中国石油大学（华东）发布5 5项仪器设备采购意向，预算总额达1 . 2 6亿元，涉及激光多普勒测振系统、空间光 感分析测试系统、水下多源传感器集成定位观测系统、高比例新能源电力系统动态模拟装置等，预计采购时间为2 0 2 5 年5~6月。 中国石油大学（华东） 2 0 2 5 年 5 ~ 6 月 仪器设备采购 意向汇总表 | 采购项目 | 需求概况 | 预 算 | 采 购 | | --- | --- | --- | --- | | | | 万 | 时 | | | | 元 | 间 | | | 激光多普勒测振仪作为高精度振动测量设备，在教学与科研中具有重要作用，其非接触式测量特性可提供纳米级振动数据，支 | | 202 | | 激光多普 | 撑工程类专业教学实验，帮助学生理解结构动力学原理，提升实践能力。科研方面，该设备能精确分析材料、设 ...